Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11884713 Acylated glucagon analogues

Patent 11884713 was granted and assigned to Zealand Pharma A/S on January, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 1 Feb, 2024
"Created via: Patent importer"
Golden AI profile picture
Golden AI
created this topic on 1 Feb, 2024
Edits made to:
Infobox (+74 properties)
Article (+390 characters)
‌

 US Patent 11884713 Acylated glucagon analogues

Article

Patent abstract

The invention provides materials and methods for the treatment of obesity and excess weight, diabetes, and other associated metabolic disorders. In particular, the invention provides novel acylated glucagon analogue peptides effective in such methods. The peptides may mediate their effect by having increased selectivity for the GLP-1 receptor as compared to human glucagon.

Infobox
Is a
Patent
Patent
0
Patent Applicant
Zealand Pharma A/S
Zealand Pharma A/S
0
Current Assignee
Zealand Pharma A/S
Zealand Pharma A/S
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
118847130
Patent Inventor Names
Dieter Wolfgang Hamprecht0
Ditte Riber0
Jakob Lind Tolborg0
Wolfgang Rist0
Date of Patent
January 30, 2024
0
Patent Application Number
173690610
Date Filed
July 7, 2021
0
Patent Citations
‌
US Patent 7115569 Exendins, exendin agonists, and methods for their use
0
‌
US Patent 7138375 Use of exendins and agonists thereof for lowering plasma lipid
0
‌
US Patent 7153825 Methods for glucagon suppression using modified exendins
0
‌
US Patent 7157555 Exendin agonist compounds
0
‌
US Patent 7220721 Exendin agonist peptides
0
‌
US Patent 7223725 Exendin agonist compounds
0
‌
US Patent 7226990 Extendin derivatives
0
‌
US Patent 7235627 Derivatives of GLP-1 analogs
0
‌
US Patent 7297761 Pharmaceutical compositions containing exendins
0
‌
US Patent 7348404 Solid-phase peptide synthesis and agent for use in such synthesis
0
‌
US Patent 7399489 Exendin analog formulations
0
‌
US Patent 7407932 Methods for glucagon suppression using modified exendins
0
‌
US Patent 7419952 Use of exendins and agonists thereof to treat diabetes
0
‌
US Patent 7442680 Inotropic and diuretic effects of GLP-1 and GLP-1 agonists
0
‌
US Patent 7452858 Treatment of gestational diabetes
0
‌
US Patent 7521423 Exendin pharmaceutical compositions
0
‌
US Patent 7544657 Stabilized Exendin-4 compounds
0
‌
US Patent 7601691 Anti-obesity agents
0
‌
US Patent 7608692 Exendins and exendin agonists modified with albumin
0
‌
US Patent 7623530 Indication of service flow termination by network control to policy decision function
0
‌
US Patent 7683030 Methods of treating diabetes with albumin-conjugated exendin peptides
0
‌
US Patent 7691963 Exendins and exendin agonists modified with polyamino acids
0
‌
US Patent 7696161 Exendin agonist compounds
0
‌
US Patent 7700549 Exendin agonist analogs to treat diabetes
0
‌
US Patent 7741269 Exendins and exendin agonists for weight reduction and obesity
0
‌
US Patent 7858740 Exendin agonist compounds
0
‌
US Patent 7928065 Methods of treatment using exendin peptides or GLP-1 peptides
0
‌
US Patent 7935786 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
0
‌
US Patent 7994122 Glucagon analogues
0
‌
US Patent 8026210 Exendins and exendin agonist analogs to regulate gastrointestinal motility
0
‌
US Patent 8057822 Modified exendins and exendin agonists
0
‌
US Patent 8097698 Derivatives of GLP-1 analogs
0
‌
US Patent 8263550 Exendin agonist compounds
0
‌
US Patent 8288338 Exendin and exendin agonists for eating disorders
0
‌
US Patent 8445647 Modified exendins and exendin agonists
0
‌
US Patent 8642540 Glucagon analogues
0
‌
US Patent 8642541 Glucagon analogues
0
‌
US Patent 8642727 Selective glucagon-like-peptide-2 (GLP-2) analogues
0
‌
US Patent 8680049 Glucagon analogues
0
‌
US Patent 8685919 Glucagon analogues
0
‌
US Patent 9089538 Peptide conjugates of GLP-1 receptor agonists and gastrin and their use
0
‌
US Patent 9156901 Acylated glucagon analogues
0
‌
US Patent 9169310 Glucagon analogues
0
‌
US Patent 9180169 Glucagon analogues
0
‌
US Patent 9403894 Glucagon analogues
0
‌
US Patent 9453064 Glucagon-like-peptide-2 (GLP-2) analogues
0
‌
US Patent 9649362 Peptide conjugates of GLP-1 receptor agonists and gastrin and their use
0
‌
US Patent 9896495 Acylated glucagon analogues
0
‌
US Patent 9969787 Glucagon-like-peptide-2 (GLP-2) analogues
0
‌
US Patent 9975939 Glucagon analogues
0
‌
US Patent 9988429 Glucagon analogues
0
‌
US Patent 10004786 Acylated glucagon analogues
0
‌
US Patent 10093713 GIP-GLP-1 dual agonist compounds and methods
0
‌
US Patent 10100097 GIP-GLP-1 dual agonist compounds and methods
0
‌
US Patent 6858576 Methods for regulating gastrointestinal motility
0
‌
US Patent 6872700 Methods for glucagon suppression
0
‌
US Patent 6902744 Exendin agonist formulations and methods of administration thereof
0
‌
US Patent 6924264 Modified exendins and exendin agonists
0
‌
US Patent 6956026 Use of exendins for the reduction of food intake
0
‌
US Patent 6989366 Exendins, exendin agonists, and methods for their use
0
‌
US Patent 7056734 Differentiation of non-insulin producing cells into insulin producing cells by GLP-1 or exendin-4 and uses thereof
0
Patent Primary Examiner
‌
Thomas S Heard
0

Find more entities like US Patent 11884713 Acylated glucagon analogues

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo